市場調査レポート

商品コード

1424044

ペプチドおよびオリゴヌクレオチドCDMO市場、シェア、規模、動向、産業分析レポート：製品別、サービス別、エンドユーザー別、地域別、セグメント別予測、2024-2032年

Peptide and Oligonucleotide CDMO Market Share, Size, Trends, Industry Analysis Report, By Product (Peptides, Oligonucleotides); By Service; By End User; By Region; Segment Forecast, 2024- 2032

出版日: 2024年01月24日 | 発行: Polaris Market Research

| ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,250 666,230円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 822,990円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 979,750円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、世界のペプチドおよびオリゴヌクレオチドCDMO市場規模は2032年までに46億4,657万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ペプチドおよびオリゴヌクレオチドCDMOは、ペプチドやオリゴヌクレオチドの複雑な合成において高度に専門化された専門知識を提供し、精度を保証します。CDMOは最適化されたプロセスとスケールメリットにより、コスト効率の高いソリューションを提供します。最先端の施設は、厳格な品質基準と規制コンプライアンスを遵守し、高度な技術を備えています。製造におけるスケーラビリティは、さまざまな医薬品開発段階におけるさまざまな需要への柔軟な適応を可能にします。

ペプチドおよびオリゴヌクレオチド受託開発には、顧客とCDMOの間で徹底的な共同作業が行われます。プロジェクトの計画段階では、両者が目的、範囲、スケジュールを綿密に定義し、クライアントの要件を包括的に理解します。その後の段階では、生体分子配列の複雑な設計と最適化、スケーラビリティのための厳格なプロセス開発、有効な分析法の確立が含まれます。規制遵守基準に沿った品質管理措置は、製造全体を通して細心の注意を払って適用されます。技術移転、詳細なプロジェクト完了報告書、継続的改善のための継続的イニシアチブは、これらの重要な生体分子のための高品質で再現可能な製造プロセスを提供することへのコミットメントを強調しています。

ペプチドおよびオリゴヌクレオチドCDMO製造機関は、オーダーメイドの合成ソリューションを提供することで、研究機関に貢献しています。これらの企業は、創薬やバイオマーカー開発など、多様な用途に特化した専門知識を有しています。研究機関は、CDMOが促進するシームレスなスケールアッププロセスから恩恵を受け、一貫した分子供給を保証します。CDMOは最先端技術を活用し、研究機関に精密な実験のための最先端手法へのアクセスを提供します。

薬事コンプライアンスのサポートは、研究プロジェクト、特にトランスレーショナル・アプリケーションの信頼性を高めます。協力的なパートナーシップは相乗効果を促進し、CDMOは研究活動に技術的な洞察力と革新的なソリューションを提供します。分析サービスは合成された分子の信頼性を保証し、柔軟なサービスモデルはダイナミックなプロジェクトのニーズに対応します。プロジェクト設計時のコンサルテーションは合成戦略を最適化し、タイムリーな納品とコスト効率へのコミットメントは研究機関への継続的な材料供給を保証します。

ペプチドおよびオリゴヌクレオチドCDMO市場レポートハイライト

2023年、ペプチド分野は、バイオ医薬品アプリケーションの増加、診断の進歩、治療の進歩により、大きな市場シェアを占めました。

2023年、受託製造分野は、アウトソーシングの専門知識、カスタマイズされた生産、コスト効率により、大きな市場シェアを占めました。

2023年、バイオ医薬品企業セグメントは、治療法開拓のための専門的サービスに対する需要の拡大、開発プロセスの合理化により、大きな市場収益シェアを占めました。

2023年には、個別化医療の需要増加、研究開発活動の活発化、技術進歩により、北米が最大の収益シェアを占めました。

同市場は、Bachem Group、CordenPharma、Creative Peptides、EUROAPI、Merck KGaA、PolyPeptide Groupなど、世界的に存在感を示す市場プレイヤーの存在により、競争が激しいです。

ペプチドおよびオリゴヌクレオチドCDMO市場- エンドユーザーのスナップショット
ペプチドおよびオリゴヌクレオチドCDMO市場力学
- 促進要因と機会
  - 接続性とスマートデバイスとのシームレスな統合に対するニーズの高まり
  - 世界の環境意識の高まりと持続可能な製品への需要により、環境に優しいペプチドおよびオリゴヌクレオチドCDMOは急速に成長しています。
- 抑制要因と課題
  - ペプチドおよびオリゴヌクレオチドCDMOの高コストが市場の成長を制限する
PESTEL分析
ペプチドおよびオリゴヌクレオチドCDMO市場のエンドユーザー動向
バリューチェーン分析
COVID-19感染症の影響分析

第5章世界のペプチドおよびオリゴヌクレオチドCDMO市場、製品別

主な調査結果
イントロダクション
ペプチド
オリゴヌクレオチド

第6章世界のペプチドおよびオリゴヌクレオチドCDMO市場、サービス別

主な調査結果
イントロダクション
受託開発
受託製造

第7章世界のペプチドおよびオリゴヌクレオチドCDMO市場、エンドユーザー別

主な調査結果
イントロダクション
バイオ医薬品企業
製薬会社
研究機関
学術機関および政府機関
その他

第8章世界のペプチドおよびオリゴヌクレオチドCDMO市場、地域別

主な調査結果
イントロダクション
- ペプチドおよびオリゴヌクレオチドCDMO市場評価、地域別、2019-2032年
ペプチドおよびオリゴヌクレオチドCDMO市場-北米
- 北米：ペプチドおよびオリゴヌクレオチドCDMO市場、製品別、2019-2032年
- 北米：ペプチドおよびオリゴヌクレオチドCDMO市場、エンドユーザー別、2019-2032年
- 北米：ペプチドおよびオリゴヌクレオチドCDMO市場、サービス別、2019-2032年
- ペプチドおよびオリゴヌクレオチドCDMO市場-米国
- ペプチドおよびオリゴヌクレオチドCDMO市場- カナダ
ペプチドおよびオリゴヌクレオチドCDMO市場- 欧州
- 欧州：ペプチドおよびオリゴヌクレオチドCDMO市場、製品別、2019年～2032年
- 欧州：ペプチドおよびオリゴヌクレオチドCDMO市場、エンドユーザー別、2019～2032年
- 欧州：ペプチドおよびオリゴヌクレオチドCDMO市場、サービス別、2019～2032年
- ペプチドおよびオリゴヌクレオチドCDMO市場- 英国
- ペプチドおよびオリゴヌクレオチドCDMO市場- フランス
- ペプチドおよびオリゴヌクレオチドCDMO市場- ドイツ
- ペプチドおよびオリゴヌクレオチドCDMO市場- イタリア
- ペプチドおよびオリゴヌクレオチドCDMO市場- スペイン
- ペプチドおよびオリゴヌクレオチドCDMO市場- オランダ
- ペプチドおよびオリゴヌクレオチドCDMO市場- ロシア
ペプチドおよびオリゴヌクレオチドCDMO市場- アジア太平洋
- アジア太平洋：ペプチドおよびオリゴヌクレオチドCDMO市場、製品別、2019年～2032年
- アジア太平洋：ペプチドおよびオリゴヌクレオチドCDMO市場、エンドユーザー別、2019～2032年
- アジア太平洋：ペプチドおよびオリゴヌクレオチドCDMO市場、サービス別、2019～2032年
- ペプチドおよびオリゴヌクレオチドCDMO市場- 中国
- ペプチドおよびオリゴヌクレオチドCDMO市場- インド
- ペプチドおよびオリゴヌクレオチドCDMO市場- マレーシア
- ペプチドおよびオリゴヌクレオチドCDMO市場- 日本
- ペプチドおよびオリゴヌクレオチドCDMO市場- インドネシア
- ペプチドおよびオリゴヌクレオチドCDMO市場- 韓国
ペプチドおよびオリゴヌクレオチドCDMO市場-中東およびアフリカ
- 中東およびアフリカ：ペプチドおよびオリゴヌクレオチドCDMO市場、製品別、2019-2032年
- 中東およびアフリカ：ペプチドおよびオリゴヌクレオチドCDMO市場、エンドユーザー別、2019～2032年
- 中東およびアフリカ：ペプチドおよびオリゴヌクレオチドCDMO市場、サービス別、2019-2032年
- ペプチドおよびオリゴヌクレオチドCDMO市場- サウジアラビア
- ペプチドおよびオリゴヌクレオチドCDMO市場-UAE
- ペプチドおよびオリゴヌクレオチドCDMO市場- イスラエル
- ペプチドおよびオリゴヌクレオチドCDMO市場- 南アフリカ
ペプチドおよびオリゴヌクレオチドCDMO市場-ラテンアメリカ
- ラテンアメリカ：ペプチドおよびオリゴヌクレオチドCDMO市場、製品別、2019-2032年
- ラテンアメリカ：ペプチドおよびオリゴヌクレオチドCDMO市場、エンドユーザー別、2019～2032年
- ラテンアメリカ：ペプチドおよびオリゴヌクレオチドCDMO市場、サービス別、2019-2032年
- ペプチドおよびオリゴヌクレオチドCDMO市場- メキシコ
- ペプチドおよびオリゴヌクレオチドCDMO市場- ブラジル
- ペプチドおよびオリゴヌクレオチドCDMO市場- アルゼンチン

第9章競合情勢

拡張と買収の分析
- 拡大
- 買収
提携/協業/合意/公開

第10章企業プロファイル

Aurigene Pharmaceutical Services Ltd.
Bachem Group
CordenPharma
Creative Peptides
Curia Global, Inc.
EUROAPI
Genscript Biotech Corporation
Lonza Group
Merck KGaA
PolyPeptide Group
Senn Chemicals AG
STA Pharmaceutical Co. Ltd.
Sylentis, S.A.
Thermo Fisher Scientific Inc.
Wuxi AppTec

図表

List of Tables

Table 1 Global Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 2 Global Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 3 Global Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 4 Peptide and Oligonucleotide CDMO Market Assessment, By Geography, 2019-2032 (USD Million)
Table 5 North America: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 6 North America: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 7 North America: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 8 U.S.: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 9 U.S.: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 10 U.S.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 11 Canada: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 12 Canada: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 13 Canada: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 14 Europe: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 15 Europe: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 16 Europe: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 17 UK: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 18 UK: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 19 UK: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 20 France: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 21 France: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 22 France: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 23 Germany: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 24 Germany: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 25 Germany: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 26 Italy: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 27 Italy: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 28 Italy: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 29 Spain: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 30 Spain: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 31 Spain: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 32 Netherlands: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 33 Netherlands: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 34 Netherlands: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 35 Russia: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 36 Russia: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 37 Russia: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 38 Asia Pacific: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 39 Asia Pacific: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 40 Asia Pacific: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 41 China: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 42 China: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 43 China: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 44 India: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 45 India: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 46 India: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 47 Malaysia: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 48 Malaysia: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 49 Malaysia: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 50 Japan: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 51 Japan: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 52 Japan: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 53 Indonesia: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 54 Indonesia: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 55 Indonesia: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 56 South Korea: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 57 South Korea: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 58 South Korea: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 59 Middle East & Africa: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 60 Middle East & Africa: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 61 Middle East & Africa: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 62 Saudi Arabia: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 63 Saudi Arabia: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 64 Saudi Arabia: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 65 UAE: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 66 UAE: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 67 UAE: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 68 Israel: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 69 Israel: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 70 Israel: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 71 South Africa: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 72 South Africa: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 73 South Africa: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 74 Latin America: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 75 Latin America: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 76 Latin America: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 77 Mexico: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 78 Mexico: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 79 Mexico: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 80 Brazil: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 81 Brazil: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 82 Brazil: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
Table 83 Argentina: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
Table 84 Argentina: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
Table 85 Argentina: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)

List of Figures

Figure 1. Global Peptide and Oligonucleotide CDMO Market, 2019-2032 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Service
Figure 7. Global Peptide and Oligonucleotide CDMO Market, by Service, 2022 & 2032 (USD Million)
Figure 8. Market by Product
Figure 9. Global Peptide and Oligonucleotide CDMO Market, by Product, 2022 & 2032 (USD Million)
Figure 10. Market by End User
Figure 11. Global Peptide and Oligonucleotide CDMO Market, by End User, 2022 & 2032 (USD Million)
Figure 12. Peptide and Oligonucleotide CDMO Market Assessment, By Geography, 2019-2032 (USD Million)
Figure 13. Strategic Analysis - Peptide and Oligonucleotide CDMO Market

Product Code: PM4342

The global Peptide and Oligonucleotide CDMO market size is expected to reach USD 4,646.57 million by 2032, according to a new study by Polaris Market Research. The report "Peptide and Oligonucleotide CDMO Market Share, Size, Trends, Industry Analysis Report, By Product (Peptides, Oligonucleotides); By Service; By End User; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Peptide and Oligonucleotide Contract Development and Manufacturing Organizations (CDMOs) offer highly specialized expertise in the intricate synthesis of peptides and oligonucleotides, ensuring precision. CDMOs offer cost-efficient solutions through optimized processes and economies of scale. Their state-of-the-art facilities adhere to rigorous quality standards and regulatory compliance, equipped with advanced technologies. Scalability in manufacturing allows for flexible adaptation to varying demands during different drug development phases.

Initiating the contract development for peptides and oligonucleotides involves a thorough collaborative endeavor between clients and CDMOs. In the project planning phase, both parties meticulously define objectives, scope, and timelines, ensuring a comprehensive understanding of client requirements. Subsequent stages encompass the intricate design and optimization of biomolecular sequences, rigorous process development for scalability, and the establishment of validated analytical methods. Quality control measures, aligned with regulatory compliance standards, are meticulously applied throughout manufacturing. Technology transfer, detailed project completion reports, and ongoing initiatives for continuous improvement underline the commitment to delivering high-quality, reproducible manufacturing processes for these essential biomolecules.

Peptide and oligonucleotide contract development and manufacturing organizations cater to research institutes by delivering tailored synthesis solutions. These entities bring specialized expertise across diverse applications, including drug discovery and biomarker development. Research institutes benefit from seamless scale-up processes facilitated by CDMOs, ensuring consistent molecule supply. CDMOs leverage state-of-the-art technologies, providing research institutions access to cutting-edge methodologies for precise experimentation.

Regulatory compliance support enhances the credibility of research projects, especially those with translational applications. Collaborative partnerships foster synergy, with CDMOs contributing technical insights and innovative solutions to research endeavors. Analytical services ensure the reliability of synthesized molecules, and flexible service models accommodate dynamic project needs. Consultation during project design optimizes synthesis strategies, and a commitment to timely delivery and cost efficiency ensures uninterrupted material supply for research institutes.

Peptide and Oligonucleotide CDMO Market Report Highlights

In 2023, the peptides segment accounted for substantial market share owing to rise in biopharmaceutical applications, diagnostic advancements, and therapeutic advancements.

In 2023, contract manufacturing segment accounted for significant market share due to outsourcing expertise, customized production, and cost efficiency.

In 2023, the biopharmaceutical companies segment held significant market revenue share due to greater demand for specialized services for therapeutic development, and streamlining of development processes.

In 2023, North America accounted for the largest revenue share due to rise in demand for personalized medicine, increased R&D activities, and technological advancements.

The market is highly competitive owing to the existence of market players with a global presence, including Bachem Group, CordenPharma, Creative Peptides, EUROAPI, Merck KGaA, and PolyPeptide Group among others.

Polaris Market Research has segmented the Peptide and Oligonucleotide CDMO market report based on product, service, end user, and region:

Peptide and Oligonucleotide CDMO, Product Outlook (Revenue - USD Million, 2019 - 2032)

Peptides
Oligonucleotides

Peptide and Oligonucleotide CDMO, Service Outlook (Revenue - USD Million, 2019 - 2032)

Contract Development
Contract Manufacturing

Peptide and Oligonucleotide CDMO, End User Outlook (Revenue - USD Million, 2019 - 2032)

Biopharmaceutical Companies
Pharmaceutical Companies
Research Institutes
Academic and Government Organizations
Others

Peptide and Oligonucleotide CDMO, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Russia
Asia Pacific
Japan
China
India
Malaysia
Indonesia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Peptide and Oligonucleotide CDMO Market Insights

4.1. Peptide and Oligonucleotide CDMO Market - End User Snapshot
4.2. Peptide and Oligonucleotide CDMO Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing need for connectivity and seamless integration with smart devices
  - 4.2.1.2. Rising environmental consciousness and the demand for sustainable products worldwide are driving the growth of eco-friendly Peptide and Oligonucleotide CDMO at rapid pace.
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost of Peptide and Oligonucleotide CDMO limit the market growth
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Peptide and Oligonucleotide CDMO Market End User Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Peptide and Oligonucleotide CDMO Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
5.3. Peptides
- 5.3.1. Global Peptide and Oligonucleotide CDMO Market, by Peptides, by Region, 2019-2032 (USD Million)
5.4. Oligonucleotides
- 5.4.1. Global Peptide and Oligonucleotide CDMO Market, by Oligonucleotides, by Region, 2019-2032 (USD Million)

6. Global Peptide and Oligonucleotide CDMO Market, by Service

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
6.3. Contract Development
- 6.3.1. Global Peptide and Oligonucleotide CDMO Market, by Contract Development, by Region, 2019-2032 (USD Million)
6.4. Contract Manufacturing
- 6.4.1. Global Peptide and Oligonucleotide CDMO Market, by Contract Manufacturing, by Region, 2019-2032 (USD Million)

7. Global Peptide and Oligonucleotide CDMO Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
7.3. Biopharmaceutical Companies
- 7.3.1. Global Peptide and Oligonucleotide CDMO Market, by Biopharmaceutical Companies, By Region, 2019-2032 (USD Million)
7.4. Pharmaceutical Companies
- 7.4.1. Global Peptide and Oligonucleotide CDMO Market, by Pharmaceutical Companies, By Region, 2019-2032 (USD Million)
7.5. Research Institutes
- 7.5.1. Global Peptide and Oligonucleotide CDMO Market, by Research Institutes, By Region, 2019-2032 (USD Million)
7.6. Academic and Government Organizations
- 7.6.1. Global Peptide and Oligonucleotide CDMO Market, by Academic and Government Organizations, By Region, 2019-2032 (USD Million)
7.7. Others
- 7.7.1. Global Peptide and Oligonucleotide CDMO Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Peptide and Oligonucleotide CDMO Market, by Geography

8.1. Key findings
8.2. Introduction
- 8.2.1. Peptide and Oligonucleotide CDMO Market Assessment, By Geography, 2019-2032 (USD Million)
8.3. Peptide and Oligonucleotide CDMO Market - North America
- 8.3.1. North America: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
- 8.3.2. North America: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
- 8.3.3. North America: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.3.4. Peptide and Oligonucleotide CDMO Market - U.S.
  - 8.3.4.1. U.S.: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.3.4.2. U.S.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.3.4.3. U.S.: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.3.5. Peptide and Oligonucleotide CDMO Market - Canada
  - 8.3.5.1. Canada: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.3.5.2. Canada.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.3.5.3. Canada: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
8.4. Peptide and Oligonucleotide CDMO Market - Europe
- 8.4.1. Europe: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
- 8.4.2. Europe.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
- 8.4.3. Europe: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.4.4. Peptide and Oligonucleotide CDMO Market - UK
  - 8.4.4.1. UK: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.4.4.2. UK.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.4.4.3. UK: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.4.5. Peptide and Oligonucleotide CDMO Market - France
  - 8.4.5.1. France: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.4.5.2. France.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.4.5.3. France: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.4.6. Peptide and Oligonucleotide CDMO Market - Germany
  - 8.4.6.1. Germany: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.4.6.2. Germany.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.4.6.3. Germany: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.4.7. Peptide and Oligonucleotide CDMO Market - Italy
  - 8.4.7.1. Italy: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.4.7.2. Italy.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.4.7.3. Italy: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.4.8. Peptide and Oligonucleotide CDMO Market - Spain
  - 8.4.8.1. Spain: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.4.8.2. Spain.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.4.8.3. Spain: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.4.9. Peptide and Oligonucleotide CDMO Market - Netherlands
  - 8.4.9.1. Netherlands: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.4.9.2. Netherlands.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.4.9.3. Netherlands: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.4.10. Peptide and Oligonucleotide CDMO Market - Russia
  - 8.4.10.1. Russia: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.4.10.2. Russia.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.4.10.3. Russia: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
8.5. Peptide and Oligonucleotide CDMO Market - Asia Pacific
- 8.5.1. Asia Pacific: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.5.4. Peptide and Oligonucleotide CDMO Market - China
  - 8.5.4.1. China: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.5.4.2. China.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.5.4.3. China: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.5.5. Peptide and Oligonucleotide CDMO Market - India
  - 8.5.5.1. India: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.5.5.2. India.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.5.5.3. India: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.5.6. Peptide and Oligonucleotide CDMO Market - Malaysia
  - 8.5.6.1. Malaysia: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.5.6.2. Malaysia.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.5.6.3. Malaysia: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.5.7. Peptide and Oligonucleotide CDMO Market - Japan
  - 8.5.7.1. Japan: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.5.7.2. Japan.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.5.7.3. Japan: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.5.8. Peptide and Oligonucleotide CDMO Market - Indonesia
  - 8.5.8.1. Indonesia: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.5.8.2. Indonesia.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.5.8.3. Indonesia: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.5.9. Peptide and Oligonucleotide CDMO Market - South Korea
  - 8.5.9.1. South Korea: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.5.9.2. South Korea.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.5.9.3. South Korea: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
8.6. Peptide and Oligonucleotide CDMO Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.6.4. Peptide and Oligonucleotide CDMO Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.6.4.2. Saudi Arabia.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.6.4.3. Saudi Arabia: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.6.5. Peptide and Oligonucleotide CDMO Market - UAE
  - 8.6.5.1. UAE: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.6.5.2. UAE.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.6.5.3. UAE: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.6.6. Peptide and Oligonucleotide CDMO Market - Israel
  - 8.6.6.1. Israel: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.6.6.2. Israel.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.6.6.3. Israel: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.6.7. Peptide and Oligonucleotide CDMO Market - South Africa
  - 8.6.7.1. South Africa: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.6.7.2. South Africa.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.6.7.3. South Africa: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
8.7. Peptide and Oligonucleotide CDMO Market - Latin America
- 8.7.1. Latin America: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
- 8.7.3. Latin America: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.7.4. Peptide and Oligonucleotide CDMO Market - Mexico
  - 8.7.4.1. Mexico: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.7.4.2. Mexico.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.7.4.3. Mexico: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.7.5. Peptide and Oligonucleotide CDMO Market - Brazil
  - 8.7.5.1. Brazil: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.7.5.2. Brazil.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.7.5.3. Brazil: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)
- 8.7.6. Peptide and Oligonucleotide CDMO Market - Argentina
  - 8.7.6.1. Argentina: Peptide and Oligonucleotide CDMO Market, by Product, 2019-2032 (USD Million)
  - 8.7.6.2. Argentina.: Peptide and Oligonucleotide CDMO Market, by End User, 2019-2032 (USD Million)
  - 8.7.6.3. Argentina: Peptide and Oligonucleotide CDMO Market, by Service, 2019-2032 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Aurigene Pharmaceutical Services Ltd.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Bachem Group
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. CordenPharma
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Creative Peptides
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Curia Global, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. EUROAPI
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Genscript Biotech Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Lonza Group
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Merck KGaA
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. PolyPeptide Group
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Senn Chemicals AG
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. STA Pharmaceutical Co. Ltd.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Sylentis, S.A.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Thermo Fisher Scientific Inc.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
10.15. Wuxi AppTec
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development

ペプチドおよびオリゴヌクレオチドCDMO市場、シェア、規模、動向、産業分析レポート：製品別、サービス別、エンドユーザー別、地域別、セグメント別予測、2024-2032年

Peptide and Oligonucleotide CDMO Market Share, Size, Trends, Industry Analysis Report, By Product (Peptides, Oligonucleotides); By Service; By End User; By Region; Segment Forecast, 2024- 2032

ペプチドおよびオリゴヌクレオチドCDMO市場レポートハイライト

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界のペプチドおよびオリゴヌクレオチドCDMO市場に関する洞察

第5章世界のペプチドおよびオリゴヌクレオチドCDMO市場、製品別

第6章世界のペプチドおよびオリゴヌクレオチドCDMO市場、サービス別

第7章世界のペプチドおよびオリゴヌクレオチドCDMO市場、エンドユーザー別

第8章世界のペプチドおよびオリゴヌクレオチドCDMO市場、地域別

第9章競合情勢

第10章企業プロファイル

List of Tables

List of Figures

Peptide and Oligonucleotide CDMO Market Report Highlights

Peptide and Oligonucleotide CDMO, Product Outlook (Revenue - USD Million, 2019 - 2032)

Peptide and Oligonucleotide CDMO, Service Outlook (Revenue - USD Million, 2019 - 2032)

Peptide and Oligonucleotide CDMO, End User Outlook (Revenue - USD Million, 2019 - 2032)

Peptide and Oligonucleotide CDMO, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Peptide and Oligonucleotide CDMO Market Insights

5. Global Peptide and Oligonucleotide CDMO Market, by Product

6. Global Peptide and Oligonucleotide CDMO Market, by Service

7. Global Peptide and Oligonucleotide CDMO Market, by End User

8. Global Peptide and Oligonucleotide CDMO Market, by Geography

9. Competitive Landscape

10. Company Profiles

ペプチドおよびオリゴヌクレオチドCDMO市場、シェア、規模、動向、産業分析レポート：製品別、サービス別、エンドユーザー別、地域別、セグメント別予測、2024-2032年

Peptide and Oligonucleotide CDMO Market Share, Size, Trends, Industry Analysis Report, By Product (Peptides, Oligonucleotides); By Service; By End User; By Region; Segment Forecast, 2024- 2032

ペプチドおよびオリゴヌクレオチドCDMO市場レポートハイライト

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のペプチドおよびオリゴヌクレオチドCDMO市場に関する洞察

第5章 世界のペプチドおよびオリゴヌクレオチドCDMO市場、製品別

第6章 世界のペプチドおよびオリゴヌクレオチドCDMO市場、サービス別

第7章 世界のペプチドおよびオリゴヌクレオチドCDMO市場、エンドユーザー別

第8章 世界のペプチドおよびオリゴヌクレオチドCDMO市場、地域別

第9章 競合情勢

第10章 企業プロファイル

List of Tables

List of Figures

Peptide and Oligonucleotide CDMO Market Report Highlights

Peptide and Oligonucleotide CDMO, Product Outlook (Revenue - USD Million, 2019 - 2032)

Peptide and Oligonucleotide CDMO, Service Outlook (Revenue - USD Million, 2019 - 2032)

Peptide and Oligonucleotide CDMO, End User Outlook (Revenue - USD Million, 2019 - 2032)

Peptide and Oligonucleotide CDMO, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Peptide and Oligonucleotide CDMO Market Insights

5. Global Peptide and Oligonucleotide CDMO Market, by Product

6. Global Peptide and Oligonucleotide CDMO Market, by Service

7. Global Peptide and Oligonucleotide CDMO Market, by End User

8. Global Peptide and Oligonucleotide CDMO Market, by Geography

9. Competitive Landscape

10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界のペプチドおよびオリゴヌクレオチドCDMO市場に関する洞察

第5章世界のペプチドおよびオリゴヌクレオチドCDMO市場、製品別

第6章世界のペプチドおよびオリゴヌクレオチドCDMO市場、サービス別

第7章世界のペプチドおよびオリゴヌクレオチドCDMO市場、エンドユーザー別

第8章世界のペプチドおよびオリゴヌクレオチドCDMO市場、地域別

第9章競合情勢

第10章企業プロファイル